SCHEMBL3753446

SCHEMBL3753446

CON=C(N)c1c(F)ccc(OCc2nc3cc(Cl)ccc3s2)c1F

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LOXL2 Q9Y4K0 1/20 0.43
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
MAPT P10636 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
PKM P14618 1/20 0.39
EPHX2 P34913 6/20 0.39
HDAC6 Q9UBN7 1/20 0.39
ALOX5 P09917 6/20 0.38
F9 P00740 1/20 0.35
F10 P00742 1/20 0.35
HPGD P15428 1/20 0.35
HSD17B10 Q99714 1/20 0.35
PPARA Q07869 3/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
HTR1A P08908 1/20 0.35
DRD2 P14416 1/20 0.35
HTR2A P28223 1/20 0.35
HTR2C P28335 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3753440 1.00 LOXL2 (0.43) LOXL2NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL3746476 0.89 LOXL2 (0.45) LOXL2NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL3746477 0.89 LOXL2 (0.45) LOXL2NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL2320663 0.85 HDAC6 (0.47) LOXL2NPC1RAB9AEPHX2HDAC6
SCHEMBL3656822 0.85 LOXL2 (0.47) LOXL2NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL3753451 0.83 LOXL2 (0.43) LOXL2NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL15689757 0.82 HDAC6 (0.48) LOXL2NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL15689586 0.82 HDAC6 (0.51) LOXL2NPC1EPHX2HDAC6ALOX5
SCHEMBL3756541 0.81 EPHX2 (0.43) LOXL2NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL3756545 0.81 EPHX2 (0.43) LOXL2NPC1RAB9AMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2203219-B1 SUBSTITUTED BENZAMIDINES AS ANTIBACTERIAL AGENTS BIOTA SCIENT MANAGEMENT (AU) 2015-02-25 EP disclosed
US-8415383-B2 Substituted benzamidines as antibacterial agents BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) 2013-04-09 US disclosed
US-20100298388-A1 SUBSTITUTED BENAMIDINES AS ANTIBACTERIAL AGENTS BIOTA EUROPE LTD. (GB) 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298388-A1 SUBSTITUTED BENAMIDINES AS ANTIBACTERIAL AGENTS ALK, CBR3, CBR1 LOXL2 575/4885NPC1 2023/4885RAB9A 3922/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.